U.S. Markets open in 2 hrs 32 mins

This Biotech Stock Just Topped Expectations — And Became Profitable

ALLISON GATLIN
This Biotech Stock Just Topped Expectations — And Became Profitable

Incyte stock popped Tuesday after the biotech topped first-quarter earnings and sales forecasts. Revenue from cancer treatment Jakafi was light, but Incyte reiterated full-year guidance.